Search Results - vi+nguyen

4 Results

Sort By:

Drug repurposing for treatment of congenital vascular malformations

Reference #: 1659 The University of South Carolina is offering licensing opportunities for Drug Repurposing for Treatment of Congenital Vascular Malformations. Background: Congenital vascular malformations (CVM) are a major threat to public health with a 1.5% incident rate in the general population. Congenital capillary malformation (CM), a.k.a.,...

Published: 7/1/2024 | Inventor(s): Wenbin Tan, Vi Nguyen, Chao Gao, Anil Jegga, Yunguan Wang, Sudhir Ghandikota, Marcelo Hochman

Keywords(s):

Category(s): Biomedical and Life Sciences, Health Sciences

Trigonelline mitigates cardiomyopathy caused by SARS-CoV-2 Spike protein under obesity

Reference #: 01642 The University of South Carolina is offering licensing opportunities for Trigonelline mitigates cardiomyopathy caused by SARS-CoV-2 spike protein under obesity. Background: Today, the spread of Coronavirus Disease 2019 (COVID-19) continues, and while millions of patients have recovered, a significant number experience prolonged...

Published: 5/17/2024 | Inventor(s): Wenbin Tan, Vi Nguyen, Taixing Cui

Keywords(s):

Category(s): Health Sciences, Biomedical and Life Sciences

Retinol Acid Pathway Modulators for Treatment of Congenital Vascular Malformation

Reference #: 01657 The University of South Carolina is offering licensing opportunities for Retinol Acid Pathway Modulators for Treatment of Congenital Vascular Malformation. Background: Congenital vascular malformations (CVM) are a major threat to public health with a 1.5% incident rate in the general population. Congenital capillary malformation...

Published: 4/25/2024 | Inventor(s): Wenbin Tan, Vi Nguyen, J. Stuart Nelson

Keywords(s):

Category(s): Biomedical and Life Sciences

Targeting Treatment For ADAM30 In Pathological Cells

Reference #: 01462 The University of South Carolina is offering licensing opportunities for Targeting treatment for ADAM30 in pathological cells Background: The treatment options for vascular malformations include conservative management, drug treatment, interventional radiology, laser therapy, excisional surgery and psychological treatment. However,...

Published: 9/3/2024 | Inventor(s): Wenbin Tan, Elaine Taine, Hui Wang, Vi Nguyen, Xialing Cao

Keywords(s): a disintegrin and metalloprotease (ADAM), antibody, biomarker, cancer, inhibitor, vascular malformation

Category(s): Health Sciences, Biomedical and Life Sciences